123 related articles for article (PubMed ID: 33796946)
21. Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.
Kim HS; Goh MJ; Kim N; Choi CG; Kim SJ; Kim JH
Radiology; 2014 Dec; 273(3):831-43. PubMed ID: 24885857
[TBL] [Abstract][Full Text] [Related]
22. Differentiation of brain abscesses from glioblastomas and metastatic brain tumors: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging before and after mathematic contrast leakage correction.
Toh CH; Wei KC; Chang CN; Ng SH; Wong HF; Lin CP
PLoS One; 2014; 9(10):e109172. PubMed ID: 25330386
[TBL] [Abstract][Full Text] [Related]
23. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.
Liu ZC; Yan LF; Hu YC; Sun YZ; Tian Q; Nan HY; Yu Y; Sun Q; Wang W; Cui GB
BMC Med Imaging; 2017 Feb; 17(1):10. PubMed ID: 28143434
[TBL] [Abstract][Full Text] [Related]
24. The Potential Role of Peritumoral Apparent Diffusion Coefficient Evaluation in Differentiating Glioblastoma and Solitary Metastatic Lesions of the Brain.
Tepe M; Saylisoy S; Toprak U; Inan I
Curr Med Imaging; 2021; 17(10):1200-1208. PubMed ID: 33726654
[TBL] [Abstract][Full Text] [Related]
25. The value of whole lesion ADC histogram profiling to differentiate between morphologically indistinguishable ring enhancing lesions-comparison of glioblastomas and brain abscesses.
Horvath-Rizea D; Surov A; Hoffmann KT; Garnov N; Vörkel C; Kohlhof-Meinecke P; Ganslandt O; Bäzner H; Gihr GA; Kalman M; Henkes E; Henkes H; Schob S
Oncotarget; 2018 Apr; 9(26):18148-18159. PubMed ID: 29719596
[TBL] [Abstract][Full Text] [Related]
26. Discrimination of capsular stage brain abscesses from necrotic or cystic neoplasms using diffusion-weighted magnetic resonance imaging.
Fertikh D; Krejza J; Cunqueiro A; Danish S; Alokaili R; Melhem ER
J Neurosurg; 2007 Jan; 106(1):76-81. PubMed ID: 17236491
[TBL] [Abstract][Full Text] [Related]
27. Discrimination Between Solitary Brain Metastasis and Glioblastoma Multiforme by Using ADC-Based Texture Analysis: A Comparison of Two Different ROI Placements.
Zhang G; Chen X; Zhang S; Ruan X; Gao C; Liu Z; Wei X
Acad Radiol; 2019 Nov; 26(11):1466-1472. PubMed ID: 30770161
[TBL] [Abstract][Full Text] [Related]
28. Glioblastoma multiforme versus solitary supratentorial brain metastasis: differentiation based on morphology and magnetic resonance signal characteristics.
Maurer MH; Synowitz M; Badakshi H; Lohkamp LN; Wüstefeld J; Schäfer ML; Wiener E
Rofo; 2013 Mar; 185(3):235-40. PubMed ID: 23196836
[TBL] [Abstract][Full Text] [Related]
29. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
[TBL] [Abstract][Full Text] [Related]
30. Diffusion-weighted MR imaging in the preoperative assessment of brain abscesses.
Leuthardt EC; Wippold FJ; Oswood MC; Rich KM
Surg Neurol; 2002 Dec; 58(6):395-402; discussion 402. PubMed ID: 12517619
[TBL] [Abstract][Full Text] [Related]
31. A quantitative study of shape descriptors from glioblastoma multiforme phenotypes for predicting survival outcome.
Chaddad A; Desrosiers C; Hassan L; Tanougast C
Br J Radiol; 2016 Dec; 89(1068):20160575. PubMed ID: 27781499
[TBL] [Abstract][Full Text] [Related]
32. Differences between primary central nervous system lymphoma and glioblastoma: topographic analysis using voxel-based morphometry.
Yamashita K; Hiwatashi A; Togao O; Kikuchi K; Momosaka D; Hata N; Akagi Y; Suzuki SO; Iwaki T; Iihara K; Honda H
Clin Radiol; 2019 Oct; 74(10):816.e1-816.e8. PubMed ID: 31400805
[TBL] [Abstract][Full Text] [Related]
33. Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study.
Makino K; Hirai T; Nakamura H; Murakami R; Kitajima M; Shigematsu Y; Nakashima R; Shiraishi S; Uetani H; Iwashita K; Akter M; Yamashita Y; Kuratsu J
Ann Nucl Med; 2011 Jul; 25(6):432-8. PubMed ID: 21404136
[TBL] [Abstract][Full Text] [Related]
34. Quantitative diffusion-weighted magnetic resonance enterography in ileal Crohn's disease: A systematic analysis of intra and interobserver reproducibility.
Yu H; Shen YQ; Tan FQ; Zhou ZL; Li Z; Hu DY; Morelli JN
World J Gastroenterol; 2019 Jul; 25(27):3619-3633. PubMed ID: 31367161
[TBL] [Abstract][Full Text] [Related]
35. Structural and advanced imaging in predicting MGMT promoter methylation of primary glioblastoma: a region of interest based analysis.
Han Y; Yan LF; Wang XB; Sun YZ; Zhang X; Liu ZC; Nan HY; Hu YC; Yang Y; Zhang J; Yu Y; Sun Q; Tian Q; Hu B; Xiao G; Wang W; Cui GB
BMC Cancer; 2018 Feb; 18(1):215. PubMed ID: 29467012
[TBL] [Abstract][Full Text] [Related]
36. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Accuracy of T1-Weighted Dynamic Contrast-Enhanced-MRI and DWI-ADC for Differentiation of Glioblastoma and Primary CNS Lymphoma.
Lin X; Lee M; Buck O; Woo KM; Zhang Z; Hatzoglou V; Omuro A; Arevalo-Perez J; Thomas AA; Huse J; Peck K; Holodny AI; Young RJ
AJNR Am J Neuroradiol; 2017 Mar; 38(3):485-491. PubMed ID: 27932505
[TBL] [Abstract][Full Text] [Related]
38. Voxel-based clustered imaging by multiparameter diffusion tensor images for glioma grading.
Inano R; Oishi N; Kunieda T; Arakawa Y; Yamao Y; Shibata S; Kikuchi T; Fukuyama H; Miyamoto S
Neuroimage Clin; 2014; 5():396-407. PubMed ID: 25180159
[TBL] [Abstract][Full Text] [Related]
39. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Prediction Based on Dynamic Contrast-Enhanced MRI and Dynamic Susceptibility Contrast-Enhanced MRI Parameters from Non-Enhancing, T2-High-Signal-Intensity Lesions in Patients with Glioblastoma.
Jo SW; Choi SH; Lee EJ; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH
Korean J Radiol; 2021 Aug; 22(8):1369-1378. PubMed ID: 33987994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
